Propanc Biopharma(PPCB)
$1.84+0.10 (+5.75%)
PPCB
Propanc Biopharma financials statements
$1.84
At close:+0.10 (+5.75%)
Want to see PPCB full AI Analyst Report?
Propanc Biopharma (PPCB) Financial Statements
83 Followers
Propanc Biopharma Financial Overview
Propanc Biopharma's market cap is currently $1.80M. The company's EPS TTM is $-284.96; its P/E ratio is -0.01; Propanc Biopharma has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -18.19M | $ -57.28M | $ -1.54M | $ -1.78M | $ -1.99M |
| EBITDA | $ -18.41M | $ -58.34M | $ -1.26M | $ -2.26M | $ -2.14M |
| Net Income | $ -18.86M | $ -58.92M | $ -1.82M | $ -2.66M | $ -2.66M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 832.01K | $ 12.09K | $ 21.09K | $ 10.05K | $ 4.07K |
| Total Assets | $ 12.78M | $ 19.63M | $ 72.36K | $ 60.33K | $ 81.65K |
| Total Debt | $ 48.31K | $ 1.73M | $ 948.27K | $ 545.92K | $ 1.04M |
| Net Debt | $ -783.70K | $ 1.71M | $ 927.19K | $ 535.87K | $ 1.04M |
| Total Liabilities | $ 3.38M | $ 5.73M | $ 3.85M | $ 3.18M | $ 3.11M |
| Stockholders' Equity | $ 9.40M | $ 13.91M | $ -3.78M | $ -3.12M | $ -3.02M |
| Cash Flow | |||||
| Free Cash Flow | $ -5.68M | $ -405.17K | $ -935.12K | $ -1.11M | $ -1.44M |
| Operating Cash Flow | $ -5.68M | $ -405.17K | $ -935.12K | $ -1.11M | $ -1.44M |
| Investing Cash Flow | $ -4.93K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 6.46M | $ 490.76K | $ 941.89K | $ 1.11M | $ 1.49M |
Currency in USD
